Clinical Trials Browser

Phase 1/2 × Recruiting × entinostat × Clear all

NCT05053971 2026-04-13

Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT03838042 2024-02-07

INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies

Phase 1/2 Recruiting

Central Nervous System Neoplasms